title: Progesterone treatment, FSH plus eCG, GnRH administration, and Day 0 Protocol for MOET programs in sheep.
abstract: The effect of various superstimulatory treatments on the number of corpora lutea, fertilization rate, and embryo yield was studied in sheep. Overall, data from 708 Merino donors and 4262 embryos were analyzed in four experiments. In Experiment 1, varying intervals of progesterone treatment (5 to 14 d) before follicle-stimulating hormone (FSH) administration did not significantly affect the proportion of responding donors, the mean number of corpora lutea, or the mean number of recovered and transferable embryos per donor. In Experiment 2, a single dose of equine chorionic gonadotropin (eCG, 200 or 300 IU) combined with the FSH treatment (i.e., given at CIDR removal) reduced the number and the quality of embryos compared with that for not giving eCG (P<0.05). In Experiment 3, one dose of gonadotropin-releasing hormone (GnRH) given 24h after CIDR removal improved the number of transferable embryos compared with that for not giving GnRH (P<0.05). In Experiment 4, the new superstimulatory Day 0 Protocol, which includes starting FSH treatment at the emergence of Wave 1 (i.e., soon after ovulation, in the absence of a large follicle), improved ovarian response, with a tendency to produce more embryos compared with that for the Traditional Protocol. In summary, this study, analyzing data from various pharmacologic treatments, allows an improvement from four to eight transferable embryos per treated donor in multiple ovulation and embryo transfer programs in sheep.
authors.affiliation: Instituto de Reproducción Animal Uruguay, Montevideo, Uruguay. alejomen@adinet.com.uy
authors.forename: A
authors.initials: A
authors.lastname: Menchaca
authors.forename: M
authors.initials: M
authors.lastname: Vilariño
authors.forename: A
authors.initials: A
authors.lastname: Pinczak
authors.forename: S
authors.initials: S
authors.lastname: Kmaid
authors.forename: J M
authors.initials: JM
authors.lastname: Saldaña
mesh_terms: D000818:Animals; D006063:Chorionic Gonadotropin / Q000008:administration & dosage / Q000494:pharmacology*; D004624:Embryo Transfer / Q000662:veterinary*; D004622:Embryo, Mammalian / Q000187:drug effects*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D006736:Horses; D008297:Male; D010062:Ovulation Induction / Q000662:veterinary*; D011374:Progesterone / Q000008:administration & dosage / Q000494:pharmacology*; D012756:Sheep / Q000235:genetics / Q000502:physiology*; D013997:Time Factors
chemical_list: D006063:Chorionic Gonadotropin; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone; D005640:Follicle Stimulating Hormone